Summary & Overview
HCPCS C9811: Electronic Ambulatory Infusion Pump for Post-Surgical Non-Opioid Pain Relief
HCPCS Level II code C9811 designates an electronic ambulatory infusion pump (e.g., sapphire pump) including all pump and disposable components when used as a qualifying Medicare non-opioid medical device for post-surgical pain relief under section 4135 of the CAA, 2023. The code formalizes coverage and billing for a class of durable medical devices that facilitate non-opioid analgesia in ambulatory and home infusion settings, an area of growing policy and clinical interest as healthcare systems seek opioid-sparing postoperative strategies.
Key payers addressed in this national overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise context on the clinical application of the device, typical sites of service, and why the code matters for postoperative pain management pathways. The publication outlines expected content readers will encounter: coverage and reimbursement benchmarks where available, relevant policy updates tied to the CAA, 2023 requirement for qualifying non-opioid devices, and the clinical rationale for ambulatory infusion pump use in postoperative care.
Where input data are not present, the text notes the absence rather than inferring details. The piece is intended to inform billing, coding, and policy stakeholders about the purpose of C9811, its service implications, and where to look for payer-specific coverage guidance.
Billing Code Overview
HCPCS Level II code C9811 describes an electronic ambulatory infusion pump, such as a sapphire pump, including all pump components and disposable components. The device is specified as a non-opioid medical device intended for post-surgical pain relief and must qualify as a Medicare non-opioid medical device under section 4135 of the CAA, 2023.
Service Type: Durable medical device (ambulatory infusion therapy) providing non-opioid postoperative analgesia
Typical Site of Service: Outpatient ambulatory setting, home infusion settings, or other non-inpatient locations where ambulatory infusion pumps are used for post-surgical pain control
Data not available in the input for payers, common modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult who underwent outpatient orthopedic surgery (for example, total knee arthroplasty or rotator cuff repair) and requires short-term, non-opioid, post‑surgical analgesia delivered at home. The patient is discharged the same day or after a brief inpatient stay with an electronic ambulatory infusion pump device (C9811) programmed to deliver continuous or intermittent local anesthetic or other qualifying non‑opioid analgesic per section 4135 of the CAA, 2023. The clinical workflow involves: preoperative counseling and device consent; device selection and programming by the surgeon, anesthesiologist, or ambulatory infusion nurse; documentation of indications and device parameters in the procedure and discharge notes; patient education on pump use, dressing care, troubleshooting, and return instructions; coordination with durable medical equipment (DME) supplier for device delivery and pick‑up; and follow‑up phone calls or clinic visit within 24–72 hours to assess pain control and device function. Typical site of service is ambulatory surgical center, hospital outpatient department, or the patient’s home when provided as DME following a qualifying surgical stay.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct Procedural Service | When reporting a separate, distinct service on the same day (e.g., separate implantation/placement procedure distinct from other billed services). |